Latest articles

Pharmaceutical giants are transforming their real estate strategies. Industry leaders are shifting from traditional property ownership to strategic lease-ownership balancing for financial efficiency and flexibility.

Historic buildings across Europe are being repurposed into modern life sciences facilities, preserving heritage while supporting innovation.

As AI reshapes both biotech and cloud computing, investors are increasingly drawn to these surprisingly similar asset classes.

Operational real estate (OpRE) combines real estate and business operations, where the return is directly linked to operational revenues.

Analysing how longer leases are delivering secure income and driving the appeal of European life sciences

We reflect on the trends and milestones from 2021 to 2024 and explore the drivers behind the sector's growth, the key investment strategies, and the insights that have shaped its trajectory.